Nations Financial Group Inc. IA ADV Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

Nations Financial Group Inc. IA ADV bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 799 shares of the company’s stock, valued at approximately $325,000.

A number of other large investors have also recently bought and sold shares of the business. Bangor Savings Bank lifted its position in shares of HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares in the last quarter. MFA Wealth Advisors LLC bought a new position in HCA Healthcare in the second quarter valued at $27,000. Unique Wealth Strategies LLC bought a new position in HCA Healthcare in the second quarter valued at $28,000. GPS Wealth Strategies Group LLC boosted its holdings in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in HCA Healthcare in the second quarter worth about $33,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 1.1 %

Shares of HCA stock opened at $345.36 on Friday. The stock has a market cap of $87.48 billion, a P/E ratio of 15.51, a price-to-earnings-growth ratio of 1.35 and a beta of 1.68. The stock has a fifty day moving average price of $387.05 and a 200 day moving average price of $357.11. HCA Healthcare, Inc. has a one year low of $237.57 and a one year high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.76%. HCA Healthcare’s payout ratio is currently 11.85%.

Insider Activity

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock worth $5,608,990 in the last 90 days. Corporate insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. Wells Fargo & Company boosted their target price on shares of HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 6th. Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Finally, Morgan Stanley began coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $385.00.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.